LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2018-08-30
2017-08-30
2016-08-30
Cash flows from operating activities
Net Income
-4,238
-6,599
-1,869
-1,215
Depreciation & amortization
35
2
1
1
Deferred income taxes
-
-
-
-
Stock based compensation
1,007
2,602
113
122
Change in working capital
-52
-371
-301
338
Accounts receivable
-
-245
-8
-6
Inventory
-112
-33
-1
-11
Accounts Payable
49
3
-40
57
Other working capital
-3,869
-2,603
-1,556
-681
Other non-cash items
166
1,844
502
112
Net cash provided by operating activites
-3,106
-2,518
-1,546
-661
Cash flows from investing activities
Investments in property, plant and equipment
-763
-85
-10
-20
Acquisitions, net
0
-70
-
-
Purchases of investments
-
-
-
-
Sales/Maturities of investments
-
-
-
-
Other investing activites
-
-
0
0
Net cash used for investing activites
-763
-155
-10
-20
Cash flows from financing activities
Debt repayment
-
-
-
-
Common stock issued
3,801
1,867
4,046
419
Common stock repurchased
-
-
-
-
Dividends Paid
-
-
-
-
Other financing activites
-
-
0
0
Net cash used privided by (used for) financing activities
3,801
1,867
3,996
514
Net change in cash
-68
-806
2,440
-167
Cash at beginning of period
2,063
2,533
93
260
Cash at end of period
1,996
1,727
2,533
93
Free Cash Flow
Operating Cash Flow
-3,106
-2,518
-1,546
-661
Capital Expenditure
-763
-85
-10
-20
Free Cash Flow
-3,869
-2,603
-1,556
-681